Sigilon Therapeutics Inc (SGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 64,737 | 107,393 | 140,468 | 162,481 | 178,864 |
| Marketable Securities | 38,618 | 16,213 | N/A | N/A | N/A |
| Receivables | 62 | 59 | 27 | 178 | 140 |
| TOTAL | $109,651 | $126,394 | $144,026 | $166,270 | $183,062 |
| Non-Current Assets | |||||
| PPE Net | 3,689 | 3,994 | 3,910 | 3,630 | 3,107 |
| Other Non-Current Assets | 12,826 | 13,981 | 15,861 | 16,221 | 17,216 |
| TOTAL | $16,515 | $17,975 | $19,771 | $19,851 | $20,323 |
| Total Assets | $126,166 | $144,369 | $163,797 | $186,121 | $203,385 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,333 | 1,667 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,040 | 2,344 | 3,226 | 4,661 | 2,006 |
| Accrued Expenses | 8,060 | 8,998 | 7,657 | 8,693 | 6,912 |
| TOTAL | $37,046 | $34,888 | $40,866 | $44,386 | $34,479 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,811 | 18,411 | 20,009 | 19,941 | 19,874 |
| Deferred Revenues | 19,206 | 17,034 | 24,310 | 25,957 | 20,134 |
| Other Non-Current Liabilities | 7,721 | 8,577 | 9,618 | 10,455 | 11,275 |
| TOTAL | $24,532 | $32,321 | $29,627 | $30,668 | $39,874 |
| Total Liabilities | $61,578 | $67,209 | $70,493 | $75,054 | $74,353 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,492 | 2,489 | 2,485 | 2,465 | 2,425 |
| Common Shares | 32 | 32 | 32 | 32 | 32 |
| Retained earnings | -227,098 | -213,239 | -195,494 | -175,338 | -154,901 |
| Other shareholders' equity | -389 | -10 | 0 | 0 | 0 |
| TOTAL | $64,588 | $77,160 | $93,304 | $111,067 | $129,032 |
| Total Liabilities And Equity | $126,166 | $144,369 | $163,797 | $186,121 | $203,385 |